VivoSim Labs, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
VivoSim Labs, Inc. (VIVS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$292.00 thousand for the 12-month period ending 2018-03-31, per its 10-K filed 2018-05-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-31
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$132.00K.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$34.00K.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$45.00K.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$81.00K.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was -$292.00K.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.39M.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$2.13M.
- VivoSim Labs, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.52M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 83 month |
|---|---|---|---|---|---|
| 2018-03-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | -$166.00K derived: sum of 2 quarters · filed 2018-05-31 | -$211.00K derived: sum of 3 quarters · filed 2018-05-31 | -$292.00K 10-K · filed 2018-05-31 | |
| 2017-12-31 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-08 | -$79.00K derived: sum of 2 quarters · filed 2018-02-08 | -$160.00K 10-Q · filed 2018-02-08 | -$442.00K derived: sum of 4 quarters · filed 2018-05-31 | |
| 2017-09-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | -$126.00K 10-Q · filed 2017-11-09 | -$408.00K derived: sum of 3 quarters · filed 2018-05-31 | -$1.06M derived: sum of 4 quarters · filed 2018-05-31 | |
| 2017-06-30 | -$81.00K 10-Q · filed 2017-08-09 | -$363.00K derived: sum of 2 quarters · filed 2018-05-31 | -$1.02M derived: sum of 3 quarters · filed 2018-05-31 | -$1.46M derived: sum of 4 quarters · filed 2018-05-31 | |
| 2017-03-31 | -$282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | -$939.00K derived: sum of 2 quarters · filed 2018-05-31 | -$1.38M derived: sum of 3 quarters · filed 2018-05-31 | -$1.39M 10-K · filed 2018-05-31 | |
| 2016-12-31 | -$657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-08 | -$1.10M derived: sum of 2 quarters · filed 2018-02-08 | -$1.11M 10-Q · filed 2018-02-08 | -$1.51M derived: sum of 4 quarters · filed 2018-05-31 | |
| 2016-09-30 | -$440.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | -$452.00K 10-Q · filed 2017-11-09 | -$855.00K derived: sum of 3 quarters · filed 2018-05-31 | -$1.02M derived: sum of 4 quarters · filed 2018-05-31 | |
| 2016-06-30 | -$12.00K 10-Q · filed 2017-08-09 | -$415.00K derived: sum of 2 quarters · filed 2018-05-31 | -$576.00K derived: sum of 3 quarters · filed 2018-05-31 | -$1.01M derived: sum of 4 quarters · filed 2018-05-31 | |
| 2016-03-31 | -$403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | -$564.00K derived: sum of 2 quarters · filed 2018-05-31 | -$1.00M derived: sum of 3 quarters · filed 2018-05-31 | -$2.13M 10-K · filed 2018-05-31 | |
| 2015-12-31 | -$161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | -$597.00K derived: sum of 2 quarters · filed 2017-02-09 | -$1.73M 10-Q · filed 2017-02-09 | -$2.38M derived: sum of 4 quarters · filed 2017-06-07 | |
| 2015-09-30 | -$436.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03 | -$1.57M 10-Q · filed 2016-11-03 | -$2.22M derived: sum of 3 quarters · filed 2017-06-07 | -$2.51M derived: sum of 4 quarters · filed 2017-06-07 | |
| 2015-06-30 | -$1.14M 10-Q · filed 2016-08-04 | -$1.78M derived: sum of 2 quarters · filed 2017-06-07 | -$2.08M derived: sum of 3 quarters · filed 2017-06-07 | -$2.41M derived: sum of 4 quarters · filed 2017-06-07 | |
| 2015-03-31 | -$650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | -$941.00K derived: sum of 2 quarters · filed 2017-06-07 | -$1.28M derived: sum of 3 quarters · filed 2017-06-07 | -$1.52M 10-K · filed 2017-06-07 | |
| 2014-12-31 | -$291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-08 | -$629.00K derived: sum of 2 quarters · filed 2016-02-08 | -$867.00K 10-Q · filed 2016-02-08 | -$988.00K derived: sum of 4 quarters · filed 2016-06-09 | |
| 2014-09-30 | -$338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-09 | -$576.00K 10-Q · filed 2015-11-09 | -$697.00K derived: sum of 3 quarters · filed 2016-06-09 | -$718.00K derived: sum of 4 quarters · filed 2016-06-09 | |
| 2014-06-30 | -$238.00K 10-Q · filed 2015-08-10 | -$359.00K derived: sum of 2 quarters · filed 2016-06-09 | -$380.00K derived: sum of 3 quarters · filed 2016-06-09 | -$393.00K derived: sum of 4 quarters · filed 2016-06-09 | |
| 2014-03-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | -$142.00K derived: sum of 2 quarters · filed 2016-06-09 | -$155.00K derived: sum of 3 quarters · filed 2016-06-09 | -$268.00K 10-K · filed 2016-06-09 | -$1.39M 10-K · filed 2014-06-10 |
| 2013-12-31 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | -$34.00K derived: sum of 2 quarters · filed 2015-02-06 | -$147.00K 10-Q · filed 2015-02-06 | -$303.00K derived: sum of 4 quarters · filed 2015-06-09 | |
| 2013-09-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07 | -$126.00K 10-Q · filed 2014-11-07 | -$282.00K derived: sum of 3 quarters · filed 2015-06-09 | ||
| 2013-06-30 | -$113.00K 10-Q · filed 2014-08-08 | -$269.00K derived: sum of 2 quarters · filed 2015-06-09 | |||
| 2013-03-31 | -$156.00K 10-K · filed 2015-06-09 | ||||
| 2012-12-31 | -$445.00K 10-K · filed 2015-06-09 | ||||
| 2012-03-31 | -$44.00K 10-K · filed 2015-06-09 | ||||
| 2011-12-31 | -$111.00K 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |